CLDN1 and cancer: As a possible mechanism accounting for the diverse roles of Kindlin-1 in cancers, we identified that Kindlin-1 downregulates Wnt signaling component Axin2 and upregulates tight junction molecules such as Claudin-1 and -3 in lung cancer cells (Zhan et al., data not shown).